Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|September 20, 2012

CAD May Result in Incomplete Image Observation

Using computer-aided detection software to help find target areas in images may result in readers missing areas not marked for viewing.

Using computer-aided detection (CAD) software to help find target areas in images may actually result in readers missing areas not marked for viewing, according to research published in the October issue of Academic Radiology.

Researchers performed two experiments as part of an eye-tracking study to determine eye movements as images were being read. Forty-seven observers with an average age of 24.3 years examined images for the targets, which were the letter “T.” Throughout the image, there were also several marks of the letter “L.”

The first experiment provided high noise and low similarity between the targets, meant to cause distraction and making the targets more difficult to locate. The second experiment used less distraction and provided more targets, making the targets easier to find.

Researchers found that although in the first experiment, observers were able to find many of the targets, guided by the CAD, this came at a cost: If targets were not in an area marked by the CAD, they were likely not located. For the second experiment, there was no noted behavioral benefit from CAD, but neither was there a cost in missed targets as there was in the first experiment.

In evaluating eye movements, the researchers saw that the CAD observers looked at a lower total area than did the non-CAD observers.

“CAD signals do not combine with observers' unaided performance in a straightforward manner,” concluded the authors. “CAD can engender a sense of certainty that can lead to incomplete search and elevated chances of missing unmarked stimuli.”


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.